Skip to main content
. 2021 Jan 10;13(3):3501–3517. doi: 10.18632/aging.202282

Figure 1.

Figure 1

Foxp3 expression in high-grade gliomas from SYSUCC and survival analysis. (A) Foxp3 expression in 72 high-grade gliomas from SYSUCC, black arrows shows the positive cells. The scale bar represents 50 μm. (B) Comparison of survival prognosis between 34 Foxp3-positive patients and 38 Foxp3-negative patients from SYSUCC (Log-Rank test).